Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessment
Autor: | Gregory Hamm, Gareth Maglennon, Beth Williamson, Ruth Macdonald, Ann Doherty, Stewart Jones, Jayne Harris, James Blades, Alexander R. Harmer, Peter Barton, Philip B. Rawlins, Paul Smith, Jon Winter-Holt, Lindsay McMurray, Julia Johansson, Paul Fitzpatrick, William McCoull, Muireann Coen |
---|---|
Rok vydání: | 2022 |
Předmět: |
Male
Mice Knockout c-Mer Tyrosine Kinase Health Toxicology and Mutagenesis Retinal Degeneration Retinal Pigment Epithelium General Medicine Toxicology Multimodal Imaging Mass Spectrometry Cell Line Rats Mice Inbred C57BL Mice Phagocytosis Animals Humans Female Rats Long-Evans Tissue Distribution sense organs Rats Wistar Photoreceptor Cells Vertebrate |
Zdroj: | Archives of Toxicology. 96:613-624 |
ISSN: | 1432-0738 0340-5761 |
Popis: | The receptor tyrosine kinase, MERTK, plays an essential role in homeostasis of the retina via efferocytosis of shed outer nuclear segments of photoreceptors. The Royal College of Surgeons rat model of retinal degeneration has been linked to loss-of-function of MERTK, and together with the MERTK knock-out mouse, phenocopy retinitis pigmentosa in humans with MERTK mutations. Given recent efforts and interest in MERTK as a potential immuno-oncology target, development of a strategy to assess ocular safety at an early pre-clinical stage is critical. We have applied a state-of-the-art, multi-modal imaging platform to assess the in vivo effects of pharmacological inhibition of MERTK in mice. This involved the application of mass spectrometry imaging (MSI) to characterize the ocular spatial distribution of our highly selective MERTK inhibitor; AZ14145845, together with histopathology and transmission electron microscopy to characterize pathological and ultra-structural change in response to MERTK inhibition. In addition, we assessed the utility of a human retinal in vitro cell model to identify perturbation of phagocytosis post MERTK inhibition. We identified high localized total compound concentrations in the retinal pigment epithelium (RPE) and retinal lesions following 28 days of treatment with AZ14145845. These lesions were present in 4 of 8 treated animals, and were characterized by a thinning of the outer nuclear layer, loss of photoreceptors (PR) and accumulation of photoreceptor outer segments at the interface of the RPE and PRs. Furthermore, the lesions were very similar to that shown in the RCS rat and MERTK knock-out mouse, suggesting a MERTK-induced mechanism of PR cell death. This was further supported by the observation of reduced phagocytosis in the human retinal cell model following treatment with AZ14145845. Our study provides a viable, translational strategy to investigate the pre-clinical toxicity of MERTK inhibitors but is equally transferrable to novel chemotypes. |
Databáze: | OpenAIRE |
Externí odkaz: |